Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 3b, Multicenter, Open-label, PCI-32765 (Ibrutinib) Long-term Extension Study
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.